Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 14226 - 14250 of 14693 in total
MK-4965 is an HIV-1 reverse transcriptase inhibitor.
Experimental
DG051 is a novel small-molecule inhibitor of leukotriene A4 hydrolase (LTA4H), the protein made by one of the genes in the leukotriene pathway that has been shown to link to risk of heart attack. DG051 is designed to decrease risk of heart attack by decreasing the production of leukotriene B4...
Investigational
Matched Description: … attack by decreasing the production of leukotriene B4 (LTB4), an end product of the leukotriene pathway and
Iguratimod is under investigation in Rheumatoid Arthritis.
Investigational
Lortalamine (LM-1404) is a selective norepinephrine reuptake inhibitor developed in the 1980s. This drug never made it past clinical trials, likely due to ocular toxicity in animals, but has been used in positron emission tomography studies to label norepinephrine transporters.
Experimental
T-62 has been used in trials studying the treatment of Postherpetic Neuralgia.
Investigational
Investigational
Experimental
Experimental
Experimental
Displaying drugs 14226 - 14250 of 14693 in total